Literature DB >> 1464623

Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts.

A Olivera1, N E Buckley, S Spiegel.   

Abstract

Sphingomyelin or the products derived from its metabolism may constitute a signaling system involved in a variety of cellular processes. The activation of a plasma membrane neutral sphingomyelinase, which catalyzes the first step in sphingomyelin turnover, has been suggested to play an important role in cellular differentiation. We have studied the effect of exogenous staphylococcal sphingomyelinase on DNA synthesis and on the composition of membrane sphingolipids in quiescent Swiss 3T3 fibroblasts. Sphingomyelinase stimulated proliferation of Swiss 3T3 cells and potentiated the mitogenic action of other growth factors, such as insulin, epidermal growth factor, and bombesin. Treatment with sphingomyelinase produced a significant decrease in sphingomyelin accompanied by a corresponding increase in ceramide levels. No significant increases were detected in the levels of products derived from ceramide, i.e. ceramide 1-phosphate, sphingosine, or sphingosine 1-phosphate. To further investigate the role of ceramide in cellular proliferation, we studied the effect of cell-permeable analogs of ceramide on DNA synthesis in quiescent Swiss 3T3 cells. Both N-hexanoylsphingosine and N-acetylsphingosine at low concentrations stimulated [3H]thymidine incorporation and acted synergistically with a wide variety of growth factors known to induce proliferation of quiescent Swiss 3T3 fibroblasts. Similar effects were observed with bovine brain ceramides. These results suggest that ceramide may be involved in the regulation of cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464623

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Sphingolipid metabolism in the regulation of bioactive molecules.

Authors:  C Luberto; Y A Hannun
Journal:  Lipids       Date:  1999       Impact factor: 1.880

2.  Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation.

Authors:  L C Edsall; G G Pirianov; S Spiegel
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 3.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 4.  An update on the biology of sphingosine 1-phosphate receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  J Lipid Res       Date:  2014-01-23       Impact factor: 5.922

5.  Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis.

Authors:  D Allan
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 6.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

7.  Ceramide, a mediator of interleukin 1, tumour necrosis factor alpha, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells.

Authors:  N Mizushima; H Kohsaka; N Miyasaka
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

8.  Focal adhesion kinase (p125FAK) and paxillin are substrates for sphingomyelinase-induced tyrosine phosphorylation in Swiss 3T3 fibroblasts.

Authors:  T Sasaki; K Hazeki; O Hazeki; M Ui; T Katada
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.

Authors:  Mariam Hammadi; Jacques-Olivier Pers; Christian Berthou; Pierre Youinou; Anne Bordron
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

10.  C(6)-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch-Injured Arteries.

Authors:  Sean M O'Neill; Dina K Olympia; Todd E Fox; J Tony Brown; Thomas C Stover; Kristy L Houck; Ronald Wilson; Peter Waybill; Mark Kozak; Steven W Levison; Norbert Weber; Linda M Karavodin; Mark Kester
Journal:  Vasc Dis Prev       Date:  2008-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.